Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 26,000 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 26,000 |
| Cost Of Revenue | 0.00 | 0.00 | 0.00 | 63,000 | 109,000 |
| Gross Profit | 0.00 | 0.00 | 0.00 | -63,000 | -83,000 |
| Selling General And Administration | 156,000 | 228,000 | 264,000 | 112,000 | 140,000 |
| Research And Development | 0.00 | 0.00 | 0.00 | 0.00 | 3,000 |
| Operating Expense | 156,000 | 228,000 | 264,000 | 286,000 | 143,000 |
| Operating Income | -156,000 | -228,000 | -264,000 | -349,000 | -226,000 |
| EBIT | -156,000 | -169,000 | -266,000 | -497,000 | -1.4M |
| Interest Expense | 17,000 | 20,000 | 21,000 | 25,000 | 108,000 |
| Interest Expense Non Operating | 17,000 | 20,000 | 21,000 | 25,000 | 108,000 |
| Interest Income | 0.00 | 0.00 | -- | -- | 0.00 |
| Interest Income Non Operating | 0.00 | 0.00 | -- | -- | 0.00 |
| Net Interest Income | -17,000 | -20,000 | -21,000 | -28,000 | -108,000 |
| Other Income Expense | -- | 59,000 | -2,000 | -145,000 | -1.1M |
| Other Non Operating Income Expenses | -- | -- | -- | 0.00 | -- |
| Special Income Charges | 0.00 | -- | -- | -129,000 | -1.1M |
| Write Off | 0.00 | -- | -- | -1.1M | 1.1M |
| Gain On Sale Of Security | -- | 59,000 | -2,000 | -16,000 | -38,000 |
| Pretax Income | -173,000 | -189,000 | -287,000 | -522,000 | -1.5M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -173,000 | -189,000 | -287,000 | -522,000 | -1.5M |
| Net Income From Continuing Operation Net Minority Interest | -173,000 | -189,000 | -287,000 | -522,000 | -1.5M |
| Net Income Including Noncontrolling Interests | -173,000 | -189,000 | -287,000 | -522,000 | -1.5M |
| Net Income Common Stockholders | -173,000 | -189,000 | -287,000 | -522,000 | -1.5M |
| Net Income | -173,000 | -189,000 | -287,000 | -522,000 | -1.5M |
| EBITDA | -156,000 | -169,000 | -266,000 | -455,000 | -1.3M |
| Normalized EBITDA | -156,000 | -228,000 | -264,000 | -310,000 | -172,000 |
| Reconciled Depreciation | 0.00 | 0.00 | 0.00 | 42,000 | 54,000 |
| Basic EPS | -0.01 | -0.01 | -0.02 | -- | -0.52 |
| Diluted EPS | -0.01 | -0.01 | -0.02 | -- | -0.52 |
| Basic Average Shares | 17.0M | 17.0M | 16.9M | -- | 2.8M |
| Diluted Average Shares | 17.0M | 17.0M | 16.9M | -- | 2.8M |
| Total Unusual Items | 0.00 | 59,000 | -2,000 | -145,000 | -1.1M |
| Total Unusual Items Excluding Goodwill | 0.00 | 59,000 | -2,000 | -145,000 | -1.1M |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -173,000 | -248,000 | -285,000 | -377,000 | -334,000 |
| Diluted NI Availto Com Stockholders | -173,000 | -189,000 | -287,000 | -522,000 | -1.5M |
| Net Income Continuous Operations | -173,000 | -189,000 | -287,000 | -522,000 | -1.5M |
| Net Non Operating Interest Income Expense | -17,000 | -20,000 | -21,000 | -28,000 | -108,000 |
| Reconciled Cost Of Revenue | 0.00 | 0.00 | 0.00 | 63,000 | 109,000 |
| Total Expenses | 156,000 | 228,000 | 264,000 | 349,000 | 252,000 |
| Total Operating Income As Reported | -156,000 | -228,000 | -264,000 | -1.6M | -1.3M |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 30,000 | 38,000 | 123,000 | 672,000 | 30,000 |
| Cash Cash Equivalents And Short Term Investments | 30,000 | 38,000 | 123,000 | 672,000 | 30,000 |
| Cash Financial | -- | -- | -- | 672,000 | -- |
| Accounts Receivable | 3,000 | 3,000 | 3,000 | 3,000 | 35,000 |
| Receivables | 6,000 | 5,000 | 4,000 | 11,000 | 40,000 |
| Inventory | -- | -- | -- | 0.00 | 0.00 |
| Current Assets | 36,000 | 43,000 | 127,000 | 683,000 | 70,000 |
| Gross PPE | -- | -- | -- | 629,000 | -- |
| Accumulated Depreciation | -- | -- | -- | -629,000 | -- |
| Net PPE | -- | -- | -- | 0.00 | 173,000 |
| Investments And Advances | 0.00 | 0.00 | 40,000 | 41,000 | 42,000 |
| Other Investments | -- | -- | -- | -- | 42,000 |
| Other Non Current Assets | -- | -- | -- | -- | 128,000 |
| Total Non Current Assets | 0.00 | 0.00 | 40,000 | 41,000 | 343,000 |
| Total Assets | 36,000 | 43,000 | 167,000 | 724,000 | 413,000 |
| Current Debt | 426,000 | 269,000 | 236,000 | 657,000 | 2.0M |
| Current Debt And Capital Lease Obligation | 601,000 | 418,000 | 350,000 | 751,000 | 2.1M |
| Accounts Payable | 599,000 | 609,000 | 528,000 | 743,000 | 629,000 |
| Payables | 784,000 | 786,000 | 684,000 | 784,000 | 1.1M |
| Payables And Accrued Expenses | 784,000 | 786,000 | 684,000 | 982,000 | 1.1M |
| Current Accrued Expenses | -- | -- | -- | 198,000 | -- |
| Current Liabilities | 1.4M | 1.2M | 1.0M | 1.7M | 3.2M |
| Long Term Debt | 317,000 | 308,000 | 291,000 | 308,000 | 359,000 |
| Long Term Debt And Capital Lease Obligation | 743,000 | 742,000 | 699,000 | 740,000 | 798,000 |
| Long Term Capital Lease Obligation | 426,000 | 434,000 | 408,000 | 432,000 | 439,000 |
| Total Non Current Liabilities Net Minority Interest | 743,000 | 742,000 | 699,000 | 740,000 | 798,000 |
| Total Liabilities Net Minority Interest | 2.1M | 1.9M | 1.7M | 2.5M | 4.0M |
| Common Stock | 10.2M | 10.2M | 10.2M | 0.00 | 8.0M |
| Capital Stock | 10.2M | 10.2M | 10.2M | 0.00 | 8.0M |
| Additional Paid In Capital | -- | -- | -- | 9.7M | -- |
| Retained Earnings | -13.0M | -12.8M | -12.6M | -12.4M | -11.8M |
| Gains Losses Not Affecting Retained Earnings | 48,000 | 64,000 | 212,000 | 186,000 | 66,000 |
| Other Equity Adjustments | 48,000 | 64,000 | 212,000 | 186,000 | 66,000 |
| Common Stock Equity | -2.1M | -1.9M | -1.6M | -1.7M | -3.5M |
| Stockholders Equity | -2.1M | -1.9M | -1.6M | -1.7M | -3.5M |
| Total Equity Gross Minority Interest | -2.1M | -1.9M | -1.6M | -1.7M | -3.5M |
| Total Capitalization | -1.8M | -1.6M | -1.3M | -1.4M | -3.2M |
| Net Tangible Assets | -2.1M | -1.9M | -1.6M | -1.7M | -3.5M |
| Tangible Book Value | -2.1M | -1.9M | -1.6M | -1.7M | -3.5M |
| Working Capital | -1.3M | -1.2M | -907,000 | -1.1M | -3.1M |
| Invested Capital | -1.3M | -1.3M | -1.0M | -784,000 | -1.1M |
| Total Debt | 1.3M | 1.2M | 1.0M | 1.5M | 2.9M |
| Net Debt | 713,000 | 539,000 | 404,000 | 293,000 | 2.4M |
| Share Issued | 17.0M | 17.0M | 17.0M | 15.3M | 2.9M |
| Ordinary Shares Number | 17.0M | 17.0M | 17.0M | 15.3M | 2.9M |
| Allowance For Doubtful Accounts Receivable | -- | -- | -- | -21,000 | -- |
| Available For Sale Securities | -- | -- | 40,000 | 41,000 | 42,000 |
| Capital Lease Obligations | 601,000 | 583,000 | 522,000 | 526,000 | 498,000 |
| Current Capital Lease Obligation | 175,000 | 149,000 | 114,000 | 94,000 | 59,000 |
| Current Notes Payable | 172,000 | 0.00 | 0.00 | 400,000 | 400,000 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | -- | -- | -- | 41,000 | 42,000 |
| Gross Accounts Receivable | -- | -- | -- | 24,000 | -- |
| Interest Payable | -- | -- | -- | 53,000 | -- |
| Investmentin Financial Assets | 0.00 | 0.00 | 40,000 | 41,000 | 42,000 |
| Land And Improvements | -- | -- | -- | 0.00 | -- |
| Leases | -- | -- | -- | 213,000 | -- |
| Machinery Furniture Equipment | -- | -- | -- | 258,000 | -- |
| Other Current Borrowings | 254,000 | 269,000 | 236,000 | 257,000 | 1.6M |
| Other Equity Interest | 694,000 | 694,000 | 694,000 | 693,000 | 182,000 |
| Other Payable | 185,000 | 177,000 | 156,000 | 41,000 | 430,000 |
| Other Properties | -- | -- | -- | 158,000 | -- |
| Other Receivables | 3,000 | 2,000 | 1,000 | 8,000 | 5,000 |
| Pensionand Other Post Retirement Benefit Plans Current | -- | -- | -- | 0.00 | -- |
| Properties | -- | -- | -- | 0.00 | -- |
| Raw Materials | -- | -- | -- | 0.00 | -- |
| Work In Process | -- | -- | -- | 0.00 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -78,000 | -242,000 | -517,000 | -85,000 | -133,000 |
| Cash Flow From Continuing Operating Activities | -78,000 | -242,000 | -517,000 | -85,000 | -133,000 |
| Depreciation And Amortization | 0.00 | 0.00 | 0.00 | 42,000 | 54,000 |
| Depreciation Amortization Depletion | 0.00 | 0.00 | 0.00 | 42,000 | 54,000 |
| Stock Based Compensation | 0.00 | 0.00 | 1,000 | 122,000 | -127,000 |
| Change In Working Capital | 54,000 | -5,000 | -242,000 | 158,000 | 172,000 |
| Changes In Account Receivables | 0.00 | 0.00 | 0.00 | 31,000 | 96,000 |
| Change In Receivables | -1,000 | -1,000 | 7,000 | 26,000 | 94,000 |
| Change In Inventory | 0.00 | 0.00 | 0.00 | 32,000 | 14,000 |
| Change In Payables And Accrued Expense | 55,000 | -4,000 | -249,000 | 100,000 | 64,000 |
| Change In Payable | 55,000 | -4,000 | -249,000 | 100,000 | 64,000 |
| Other Non Cash Items | 46,000 | 12,000 | 8,000 | -14,000 | 78,000 |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Purchase Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | 14,000 |
| Net PPE Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | 14,000 |
| Sale Of Investment | 0.00 | -- | -- | -- | 0.00 |
| Net Investment Purchase And Sale | 0.00 | -- | -- | -- | 0.00 |
| Investing Cash Flow | 0.00 | 100,000 | 0.00 | 129,000 | 12,000 |
| Cash Flow From Continuing Investing Activities | 0.00 | 100,000 | 0.00 | 129,000 | 12,000 |
| Issuance Of Debt | 158,000 | -- | -- | 134,000 | 412,000 |
| Repayment Of Debt | -35,000 | 0.00 | 0.00 | -152,000 | -20,000 |
| Net Issuance Payments Of Debt | 158,000 | 0.00 | -35,000 | -18,000 | -8,000 |
| Issuance Of Capital Stock | -- | -- | -- | 647,000 | -- |
| Net Common Stock Issuance | -- | -- | -- | 647,000 | -- |
| Financing Cash Flow | 158,000 | 0.00 | -35,000 | 629,000 | -8,000 |
| Cash Flow From Continuing Financing Activities | 158,000 | 0.00 | -35,000 | 629,000 | -8,000 |
| Effect Of Exchange Rate Changes | -88,000 | 57,000 | 3,000 | -31,000 | 42,000 |
| Changes In Cash | 80,000 | -142,000 | -552,000 | 673,000 | -129,000 |
| Beginning Cash Position | 38,000 | 123,000 | 672,000 | 30,000 | 117,000 |
| End Cash Position | 30,000 | 38,000 | 123,000 | 672,000 | 30,000 |
| Free Cash Flow | -78,000 | -242,000 | -517,000 | -85,000 | -119,000 |
| Interest Paid Supplemental Data | 8,000 | 0.00 | 10,000 | 22,000 | 7,000 |
| Asset Impairment Charge | -- | -- | -- | 129,000 | -- |
| Change In Account Payable | 32,000 | 34,000 | -210,000 | 138,000 | 61,000 |
| Common Stock Issuance | -- | -- | -- | 647,000 | -- |
| Depreciation | 0.00 | 0.00 | 0.00 | 42,000 | 54,000 |
| Gain Loss On Investment Securities | -3,000 | -60,000 | 3,000 | -4,000 | 38,000 |
| Long Term Debt Issuance | 158,000 | -- | -- | -266,000 | 12,000 |
| Long Term Debt Payments | 0.00 | 0.00 | 0.00 | -152,000 | -20,000 |
| Net Foreign Currency Exchange Gain Loss | -2,000 | 0.00 | 0.00 | -- | -8,000 |
| Net Income From Continuing Operations | -173,000 | -189,000 | -287,000 | -522,000 | -1.5M |
| Net Long Term Debt Issuance | 158,000 | 0.00 | 0.00 | -418,000 | -8,000 |
| Net Other Investing Changes | -- | -- | -- | -- | -2,000 |
| Net Short Term Debt Issuance | 0.00 | 0.00 | -35,000 | -- | 0.00 |
| Operating Gains Losses | -5,000 | -60,000 | 3,000 | 0.00 | 30,000 |